全文获取类型
收费全文 | 5902篇 |
免费 | 501篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 224篇 |
妇产科学 | 126篇 |
基础医学 | 734篇 |
口腔科学 | 96篇 |
临床医学 | 719篇 |
内科学 | 1281篇 |
皮肤病学 | 50篇 |
神经病学 | 464篇 |
特种医学 | 148篇 |
外科学 | 1007篇 |
综合类 | 113篇 |
一般理论 | 2篇 |
预防医学 | 606篇 |
眼科学 | 119篇 |
药学 | 385篇 |
中国医学 | 15篇 |
肿瘤学 | 276篇 |
出版年
2023年 | 30篇 |
2022年 | 45篇 |
2021年 | 87篇 |
2020年 | 73篇 |
2019年 | 98篇 |
2018年 | 115篇 |
2017年 | 90篇 |
2016年 | 97篇 |
2015年 | 117篇 |
2014年 | 144篇 |
2013年 | 230篇 |
2012年 | 409篇 |
2011年 | 387篇 |
2010年 | 192篇 |
2009年 | 167篇 |
2008年 | 303篇 |
2007年 | 362篇 |
2006年 | 361篇 |
2005年 | 377篇 |
2004年 | 388篇 |
2003年 | 331篇 |
2002年 | 269篇 |
2001年 | 123篇 |
2000年 | 113篇 |
1999年 | 122篇 |
1998年 | 69篇 |
1997年 | 63篇 |
1996年 | 41篇 |
1995年 | 38篇 |
1994年 | 44篇 |
1993年 | 45篇 |
1992年 | 60篇 |
1991年 | 84篇 |
1990年 | 72篇 |
1989年 | 61篇 |
1988年 | 58篇 |
1987年 | 58篇 |
1986年 | 47篇 |
1985年 | 51篇 |
1984年 | 42篇 |
1983年 | 44篇 |
1981年 | 36篇 |
1980年 | 31篇 |
1979年 | 35篇 |
1978年 | 29篇 |
1976年 | 39篇 |
1975年 | 31篇 |
1974年 | 26篇 |
1973年 | 32篇 |
1972年 | 26篇 |
排序方式: 共有6420条查询结果,搜索用时 15 毫秒
91.
Rosie Ashbolt Jenny Barralet Robert Bell Dennis Bittisnich Andrew Black Barry Combs Christine Carson Scott Crerar Craig Dalton Joy Gregory Michelle Harlock Gillian Hall Geoff Hogg Martyn Kirk Karin Lalor Tony Merritt Sally Munnoch Jennie Musto Lillian Mwanri Leonie Neville Chris Oxenford Rhonda Owen Jane Raupach Cameron Sault Russell Stafford Barbara Telfer Hassan Vally Kefle Yohannes 《Communicable diseases intelligence》2005,29(1):85-88
92.
Postnatal development of NR1, NR2A and NR2B immunoreactivity in the visual cortex of the rat 总被引:4,自引:0,他引:4
N-Methyl-D-aspartate receptors (NMDARs) are critically involved in some types of synaptic plasticity. The NMDAR subunits NR1, NR2A and NR2B are developmentally regulated, and it has been proposed that developmental changes in their expression may underlie developmental changes in cortical plasticity. Age-dependent change in cortical plasticity is most commonly measured by the monocular deprivation effect, which occurs during a critical period between P22 and P50 in the rat. Although the development of NMDAR subunits has been studied from birth through the fourth postnatal week, there is only meager information from older ages when visual plasticity ends. We hypothesized that there will be significant age-dependent change in expression of NR1, NR2A or NR2B between P22, when the cortex is plastic, and P90, when it is not. We applied specific antibodies recognizing NR1, NR2A and NR2B to the primary visual cortex at P14, P22, P30, P45 and P90. We found age-dependent changes in NR1-IR that were negatively correlated with changes in NR2A-IR; these subunits are not regulated in unison. In contrast, NR2A-IR and NR2B-IR were positively correlated. NR2A-IR and NR2B-IR both passed through a developmental minimum around P45, then recovered to approximately their P22 level. NR1-IR passed through a maximum at P45. There were no significant differences between P22 and P90. These results do not support the simple hypothesis that the loss of plasticity corresponds to a simple transition from juvenile levels of NMDAR subunit proteins to new adult levels. On the other hand, the results do confirm the hypothesis that there are significant changes in processing of NMDAR proteins during the time that plasticity is lost. How these changes of IR relate to synaptic transmission and plasticity needs to be clarified. 相似文献
93.
Although relatively common in adults, leiomyoma of the esophagus is a rare disorder in children. A single case report describes the coexistence of both esophageal and bronchial leiomyoma in a child. The authors describe the diagnostic and treatment challenges encountered in a 2-year-old boy with coexisting inflammatory pseudotumor and esophageal leiomyoma presenting as massive atelectasis. 相似文献
94.
Keflemariam Yohannes Paul Roche Charlie Blumer Jenean Spencer Alison Milton Chris Bunn Heather Gidding Martyn Kirk Tony Della-Porta 《Communicable diseases intelligence》2004,28(1):6-68
There were 57 infectious diseases notifiable at the national level in Australia in 2002. States and territories reported 100,278 cases of infectious diseases to the National Notifiable Diseases Surveillance System (NNDSS), a fall of 4 per cent compared to the number of notifications in 2001. In 2002, the most frequently notified diseases were, sexually transmitted infections (31,929 reports, 32% of total notifications), gastrointestinal infections (26,708 reports, 27% of total notifications) and bloodborne infections (23,741, 24%). There were 11,711 (12% of total) cases of vaccine preventable diseases, 3,052 (3% of total) cases of vectorborne diseases, 1,155 (1% of total) cases of zoonotic infections, two cases of quarantinable diseases (Vibrio cholerae O1) and 1,980 cases of other bacterial diseases, notified to NNDSS. Compared to 2001, notifications of sexually transmitted infections increased by 16 per cent and gastrointestinal infections by 2 per cent while bloodborne infections fell by 18 per cent. The number of notifications of chlamydial infection and Q fever were the highest since 1991 and 1995 respectively. By contrast, the number of notification for hepatitis A and measles were the lowest since 1991. For other notifiable diseases, the number of notifications was within the range of the five years between 1997 and 2002 (range = five-year mean plus or minus two standard deviations). This report also includes 2002 summary data on communicable diseases from other surveillance systems including the Laboratory Virology and Serology Reporting Scheme and sentinel general practitioner schemes. 相似文献
95.
96.
Gregory D Kirk Paul C Turner Yunyun Gong Olufunmilayo A Lesi Maimuna Mendy James J Goedert Andrew J Hall Hilton Whittle Pierre Hainaut Ruggero Montesano Christopher P Wild 《Cancer epidemiology, biomarkers & prevention》2005,14(2):373-379
High rates of hepatocellular carcinoma (HCC) in The Gambia, West Africa, are primarily due to a high prevalence of chronic hepatitis B virus infection and heavy aflatoxin exposure via groundnut consumption. We investigated genetic polymorphisms in carcinogen-metabolizing (GSTM1, GSTT1, HYL1*2) and DNA repair (XRCC1) enzymes in a hospital-based case-control study. Incident HCC cases (n = 216) were compared with frequency-matched controls (n = 408) with no clinically apparent liver disease. Although the prevalence of variant genotypes was generally low, in multivariable analysis (adjusting for demographic factors, hepatitis B virus, hepatitis C virus, and TP53 status), the GSTM1-null genotype [odds ratio (OR), 2.45; 95% confidence interval (95% CI), 1.21-4.95] and the heterozygote XRCC1-399 AG genotype (OR, 3.18; 95% CI, 1.35-7.51) were significantly associated with HCC. A weak association of the HYL1*2 polymorphism with HCC was observed but did not reach statistical significance. GSTT1 was not associated with HCC. The risk for HCC with null GSTM1 was most prominent among those with the highest groundnut consumption (OR, 4.67; 95% CI, 1.45-15.1) and was not evident among those with less than the mean groundnut intake (OR, 0.64; 95% CI, 0.20-2.02). Among participants who had all three suspected aflatoxin-related high-risk genotypes [GSTM1 null, HLY1*2 (HY/HH), and XRCC1 (AG/GG)], a significant 15-fold increased risk of HCC was observed albeit with imprecise estimates (OR, 14.7; 95% CI, 1.27-169). Our findings suggest that genetic modulation of carcinogen metabolism and DNA repair can alter susceptibility to HCC and that these effects may be modified by environmental factors. 相似文献
97.
The power of positive deviance 总被引:1,自引:0,他引:1
David R Marsh Dirk G Schroeder Kirk A Dearden Jerry Sternin Monique Sternin 《British medical journal》2004,329(7475):1177-1179
98.
99.
Samuel G. Campbell Kirk Magee Ismail Cajee Simon Field Michael B. Butler Christine L. Campbell Sarah E. Bryson 《世界急诊医学杂志(英文)》2021,12(3):221-224
Dear editor,
Chest pain is a frequent complaint of patients presenting to the emergency department(ED),and many of them are referred to the cardiology service f... 相似文献
100.
Kelcey Winchar Pascal Lambert Kirk J. McManus Bernie Chodirker Sarah Kean Kim Serfas Kathleen Decker Mark W. Nachtigal Alon D. Altman 《Current oncology (Toronto, Ont.)》2022,29(12):9365
Simple SummaryThis study was performed to better understand rates and factors that influence patients in accepting a referral to genetics or testing for genes that predispose them to ovarian cancer (BRCA1/2). Using multiple provincial databases and registries, the study team looked at data from 944 patients with high-grade ovarian cancer between 2004–2019. We found that the rate of genetic referrals fluctuated over time; however, the rate of genetic testing increased over the entire timeframe. Factors found to increase rates of referral and testing included age, cancer histology, history of oral contraceptive use, and family history of ovarian cancer. Increasing the rate of genetic testing will help patients and their health care team plan clinical management and treatment.Abstract(1) Background: The primary objective of this study was to examine the rate of genetic referral, BRCA testing, and BRCA positivity amongst all patients with high-grade serous ovarian cancers (HGSOC) from 2004–2019. The secondary objective was to analyze secondary factors that may affect the rates of referral and testing. (2) Methods: This population-based cohort study included all women diagnosed with HGSOC using the Manitoba Cancer Registry, CervixCheck registry, Medical Claims database at Manitoba Health, the Hospital Discharge abstract, the Population Registry, and Winnipeg Regional Health Authority genetics data. Data were examined for three different time cohorts (2004–2013, 2014–2016; 2017–2019) correlating to practice pattern changes. (3) Results: A total of 944 patients were diagnosed with HGSOC. The rate of genetic referrals changed over the three timeframes (20.0% → 56.7% → 36.6%) and rate of genetic testing increased over the entire timeframe. Factors found to increase rates of referral and testing included age, histology, history of oral contraceptive use, and family history of ovarian cancer. Prior health care utilization indicators did not affect genetic referral or testing. (4) Conclusion: The rate of genetic referral (2004–2016) and BRCA1/2 testing (2004–2019) for patients with a diagnosis of HGSOC increased over time. A minority of patients received a consultation for genetics counselling, and even fewer received testing for a BRCA1/2. Without a genetic result, it is difficult for clinicians to inform treatment decisions. Additional efforts are needed to increase genetics consultation and testing for Manitoban patients with HGSOC. Effects of routine tumour testing on rates of genetic referral will have to be examined in future studies. 相似文献